drugset / Trial / NCT03462108

Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates

NCT03462108 ↗

Phase 1 Completed 100 enrolled PT Bio Farma
RandomizedParallel-groupDouble-blindPrevention

Summary

This study is to assess the safety of Rotavirus (Bio Farma) vaccine in adults, children and neonates.

Timeline

Start
2018-04-09
Primary completion
2019-02-18
Completion
2019-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotavirus (Bio Farma) Vaccine Vaccine 1 ml Oral

Indications

No indication recorded.